Streetbeat News

Price Targets

NVDA

Evercore ISI Group analyst Mark Lipacis initiates coverage on NVIDIA (NASDAQ:NVDA) with an Outperform rating and a price target of $1160.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 9:20 am

MT

Deutsche Bank analyst Bastian Synagowitz downgraded ArcelorMittal (NYSE:MT) from Buy to Hold and reduced the price target from $34 to $31.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 9:17 am

HON

Deutsche Bank analyst Nicole Deblase downgraded Honeywell Intl (NASDAQ:HON) from Buy to Hold and reduced the price target from $227 to $215.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 9:15 am

CCK

Baird analyst Ghansham Panjabi upgrades Crown Holdings (NYSE:CCK) from Neutral to Outperform and raises the price target from $85 to $90.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 9:13 am

BERY

Baird analyst Ghansham Panjabi downgraded Berry Global Group (BERY) from Outperform to Neutral and reduced the price target from $68 to $65.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 9:10 am

TSLA

Tesla Inc (NASDAQ:TSLA) has halved the price of its 'full self-driving' (FSD) subscription to $99 per month, a move that Gene Munster of Deepwater Asset Management believes signals the end of manual driving. This price reduction is part of Tesla's strategy to make its self-driving technology more accessible, amidst a challenging period for the company, including a 10% workforce reduction and a 20% drop in deliveries. Nvidia's Senior Lead of Robotics praised Tesla's FSD feature, while Tesla CEO Elon Musk continues to push boundaries in AI with his venture, xAI.

Portfolio Pulse from Benzinga Neuro

April 16, 2024 | 3:20 am

MS

Morgan Stanley has released a list of top 'alpha' stocks in the Asia-Pacific region, highlighting Hana Financial Group with a 28% upside potential and Novatek Microelectronics for its growth prospects. The selection comes amid global market shifts and warnings of potential corrections, yet the long-term bull rally is expected to continue.

Portfolio Pulse from Benzinga Neuro

April 16, 2024 | 3:12 am

CRLBF

CURLF

GTBIF

SHWZ

The Viridian Cannabis Deal Tracker reports a 39% increase in market value for major cannabis companies, with valuation multiples rising for 11 out of 14 major multi-state operators (MSOs). This growth is attributed to investors betting on long-term growth over short-term earnings, with companies like Curaleaf (CURLF) and Schwazze (SHWZ) experiencing valuation increases despite flat or declining EBITDA. GTI (GTBIF) and Cresco (CRLBF) also saw increases in both EBITDA multiples and estimates, indicating strong fundamentals. The anticipation of cannabis rescheduling is driving multiple expansions, with a focus on EBITDA growth as a key indicator of corporate health.

Portfolio Pulse from Nicolás Jose Rodriguez

April 15, 2024 | 11:53 pm

ZI

ZoomInfo Technologies (NASDAQ:ZI) has been analyzed by 16 analysts over the last three months, showing a mix of bullish to bearish sentiments. The recent evaluations indicate a shift towards a more cautious stance, with an increase in 'Indifferent' ratings in the last 30 days. The 12-month price targets suggest an average target of $21.47, reflecting a 4.02% increase from the previous target. Analyst actions include a range of 'Maintain', 'Raise', and 'Lower' recommendations, with price targets varying from $13.00 to $28.00. ZoomInfo's financial health shows positive revenue growth but below-average profitability and high debt levels.

Portfolio Pulse from Benzinga Insights

April 15, 2024 | 8:02 pm

PRA

ProAssurance (NYSE:PRA) has been the subject of 5 analyst ratings in the last three months, showing a mix of bullish and indifferent sentiments. The average 12-month price target among analysts is $19.4, with a high of $24.00 and a low of $14.00, marking a slight decrease from the previous average of $19.75. Analyst actions include maintaining and lowering ratings, with price targets adjusted accordingly. ProAssurance's financial health indicators reveal challenges in revenue growth and asset utilization, but strong net margin performance. The company's market capitalization is below industry averages, indicating a smaller scale relative to peers.

Portfolio Pulse from Benzinga Insights

April 15, 2024 | 8:01 pm